Intrinsic Value of S&P & Nasdaq Contact Us

Danaher Corporation DHR-PB NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Danaher Corporation (DHR-PB) has shown declining revenue growth over the past 3 years, expanding from $31.5B to $24.6B (average -7.1%/yr). Net income reached $3.6B, reflecting earnings decline at -19.8%/yr on average. The net profit margin is 14.7%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 60.9% (high), with a +0.7pp trend over the period. With a $917B market cap and MOAT composite score of 92/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (15/100, Fail) — revenue or earnings are not growing
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 41 of 41 years — a perfect long-term track record
  • INCOME (55/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (92/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.

62/100
SG Score
View full scorecard →
VALUE
15/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
55/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $5.04
Proven by this page
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
92/100
Score: 92/100
GM 60.9% (+0.7pp)
Proven by this page
GROWTH
15/100
Rev -7.1%/yr
NI -19.8%/yr
Proven by this page
~
INCOME
55/100
Margin 14.7%
$24.6B
Proven by this page
Danaher Corporation Earnings and Revenue History
Revenue
Earnings & Profit Margin
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $24.57B$24.57B$23.88B$23.89B$31.47B
Gross Profit $14.96B$14.97B$14.21B$14.03B$18.95B
Gross Margin 60.9%60.9%59.5%58.7%60.2%
Operating Income $5.12B$5.14B$4.86B$5.2B$8.69B
Net Income $3.61B$3.61B$3.9B$4.76B$7.21B
Net Margin 14.7%14.7%16.3%19.9%22.9%
EPS (Diluted) $5.04$5.04$5.29$6.38$9.64
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message